Catch up on today’s top five analyst upgrades with this list compiled by The Fly: 1. D.R. Horton (DHI) double upgraded to Buy from Sell at Goldman Sachs with analyst Susan Maklari saying the stock can outperform, even in a weaker demand environment, given D.R. Horton’s land profile, with 61% of lots optioned, and below average leverage. 2. Bristol-Myers (BMY) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst David Risinger saying the stock pullback presents an opportunity given the company’s relatively good earnings visibility during COVID-19 pandemic. 3. Disney (DIS) upgraded to Overweight from Neutral at Atlantic Equities with analyst Hamilton Faber saying while he has “materially cut” his estimates as he assumes the parks shut down persists for the rest of the fiscal year, underlying advertising declines 10% going forward and cord cutting increases from the June quarter onward due to a lack of fresh content, he also contends that the stock’s slide has been overdone with Disney shares down around 35% since the start of the coronavirus crisis. 4. SAIC (SAIC) upgraded to Buy from Hold at Stifel with analyst Joseph DeNardi saying he believes the company can achieve the low-end of its 3%-6% organic growth expectation even with award activity disruptions. 5. Armstrong World (AWI) upgraded to In Line from Underperform at Evercore ISI. This list is just a portion of The Fly’s full analyst coverage. To see The Fly’s full Street Research coverage, (click here.):(http://thefly.com/streetResearch.php)
previous post
next post